Hanqing Xie, Ph. D.
President / Owner
Synatom Research LLC
LinkedIn Page
As the senior most position within the organization, Dr. Pace is responsible for helping to set the direction of the Center, including the establishment of near-term and long-term strategic and operating plans in partnership with the Executive Committee and founders of the Center.
He is an experienced biotech/pharmaceutical industry scientist with more than 25 years’ experience spanning pathogenesis research, and antibiotic and vaccine R&D. He has led efforts that resulted in the evaluation of 14 clinical candidates, and the approved antibiotic drugs AvyCaz, Altabax/Altargo, and Vibativ the latter of which he is also co-inventor.
He has worked for anti-infective companies on both coasts, as well as in France and Denmark, and is an Adjunct Associate Professor with the Biomanufacturing Research Institute and Technology Enterprise-North Carolina Central University.
